Clinical Study
Management of Bladder Cancer following Solid Organ Transplantation
Table 2
Characteristics of patients with muscle-invasive TCC of the bladder.
| Patient number | 1 | 2 | 3 | 4 |
| Age at transplant | 38 | 58 | 60 | 66 | Type of transplant | Renal | Liver | Renal | Renal | Age at diagnosis | 44 | 60 | 63 | 70 | Immunosuppression | FK, Pred | FK, MMF, Pred | FK, Pred | FK, Pred | Pathologic stage | T3aN0M0 | T3N2M0 | T2N0M0 | T2N0M1 | Histology | TCC, CIS | TCC | TCC | TCC | Grade | High | High | High | High | Treatment | Cystectomy, allograft nephrostomy | Cystectomy, neobladder | Palliative XRT, Ileal conduit | Palliative XRT | Followup (months) | 24 | 36 | 16 | 12 | Metastasis (months) | None | None | None | Liver, pulmonary (12) | Status | Alive | Alive | Deceased (DIC) | Deceased |
|
|
FK: tacrolimus; MMF: mycophenolate mofetil; Pred: prednisone; CIS: carcinoma in site; TURBT: transurethral resection of bladder tumor; DIC: disseminated intravascular coagulation; XRT: external beam radiotherapy.
|